Intravenous gammaglobulins in refractory polymyositis: Lower dose for maintenance treatment is effective

Annals of the Rheumatic Diseases

Volumn 60, Issue 6, 2001, Pages 635-636

  Genevay, S ^a   Saudan Kister, A ^a   Guerne, P A ^a  

^a Hôpital universitaire   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; IMMUNOGLOBULIN; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; COST EFFECTIVENESS ANALYSIS; DOSE CALCULATION; DRUG EFFICACY; HUMAN; MALE; POLIOMYELITIS; PRIORITY JOURNAL; RECURRENT DISEASE;

DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; POLYMYOSITIS;

EID: 0035020554     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.6.635     Document Type: Article

References (7)

1. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis [see comments].
2. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients
3. Immunoglobulin therapy in inflammatory myopathies
4. Immunoglobulins in hematology. Immunologic thrombopenic purpura
5. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases
6. Mechanism of intravenous immune globulin therapy
7. Treatment of acute idiopathic thrombocytopenic purpura (AITP): Cooperative Italian study group results